Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1994-12-22
pubmed:abstractText
Vertebrates are highly sensitive to both retinoic acid (RA) deficiency and excess. The RA signal is thought to be transduced by nuclear receptors (the RAR and RXR families) which activate the expression of target genes via cis-acting transcriptional enhancer elements. Each of the three RAR genes, RAR alpha, RAR beta, and RAR gamma, gives rise to several isoforms by differential usage of two promoters and alternative splicing. RAR beta 2 is the most abundant of the four RAR beta isoforms, and its transcription is spatially and temporally restricted in developing embryos, suggesting that it might perform specific functions. Furthermore, RAR beta 2 expression can be induced via a retinoic acid response element located in its promoter region. This RA effect is particularly interesting since under conditions of RA excess, RAR beta 2 promoter activity and transcript accumulation are induced in regions of developing embryos in which malformations subsequently appear, such as the craniofacial region, the hindbrain, and the limbs. These findings have led to the suggestion that the RAR beta 2 isoform might mediate some of the teratogenic effects of RA. In this study, we have eliminated RAR beta 2 expression by targeted gene disruption. RAR beta 2 null mutants exhibit an apparently normal phenotype, indicating that other RARs must compensate for RAR beta 2 sufficiently well to allow normal prenatal and postnatal development to proceed. By challenging RAR beta 2 null embryos with teratogenic doses of RA, we have also directly addressed the question of whether RAR beta 2 is required for mediating RA-induced malformations.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0012-1606
pubmed:author
pubmed:issnType
Print
pubmed:volume
166
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
246-58
pubmed:dateRevised
2011-8-1
pubmed:meshHeading
pubmed-meshheading:7958449-Animals, pubmed-meshheading:7958449-Base Sequence, pubmed-meshheading:7958449-Blotting, Southern, pubmed-meshheading:7958449-Crosses, Genetic, pubmed-meshheading:7958449-DNA, pubmed-meshheading:7958449-Embryo, Mammalian, pubmed-meshheading:7958449-Embryo, Nonmammalian, pubmed-meshheading:7958449-Embryonic and Fetal Development, pubmed-meshheading:7958449-Exons, pubmed-meshheading:7958449-Female, pubmed-meshheading:7958449-Heterozygote, pubmed-meshheading:7958449-Male, pubmed-meshheading:7958449-Mice, pubmed-meshheading:7958449-Mice, Mutant Strains, pubmed-meshheading:7958449-Molecular Sequence Data, pubmed-meshheading:7958449-Mutagenesis, Site-Directed, pubmed-meshheading:7958449-Oligodeoxyribonucleotides, pubmed-meshheading:7958449-Phenotype, pubmed-meshheading:7958449-Promoter Regions, Genetic, pubmed-meshheading:7958449-Receptors, Retinoic Acid, pubmed-meshheading:7958449-Repetitive Sequences, Nucleic Acid, pubmed-meshheading:7958449-Restriction Mapping, pubmed-meshheading:7958449-Transcription, Genetic, pubmed-meshheading:7958449-Vertebrates
pubmed:year
1994
pubmed:articleTitle
Retinoic acid receptor beta 2 (RAR beta 2) null mutant mice appear normal.
pubmed:affiliation
Laboratoire de Génétique Moléculaire des Eucaryotes du CNRS, Institut de Chimie Biologique, Faculté de Médecine, Strasbourg, France.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't